Literature DB >> 31918951

Comparing a thioglycosylated chlorin and phthalocyanine as potential theranostic agents.

Sunaina Singh1, Amit Aggarwal2, N V S Dinesh K Bhupathiraju3, Ivana Radivojevic Jovanovic4, Michael Landress5, Michelle Paola Tuz5, Ruomei Gao6, Charles M Drain7.   

Abstract

Herein we describe the design, efficient synthesis, and photophysical properties of two macrocycle dyes for cancer theranostics. This study compares a glycosylated chlorin with a glycosylated phthalocyanine designed to specifically target cancer, wherein the photophysical properties enable both fluorescence imaging and the sensitization of the formation of reactive oxygen species (ROS) for photodynamic therapy. Both the compounds show low darktoxicity (IC50 > 100 μM). The glycosylated phthalocyanine showed low phototoxicity (IC50 > 100 μM) while glycosylated chlorin showed high phototoxicity (IC50 = 1-2 μM). ZnPcGlc8 has low solubility and also form aggregates in aqueous media, thus resulting in minimal uptake in two different human breast cancer cell lines: MDA-MB-231 and MCF-7. The glycosylated chlorin however was efficiently taken up by these two cell lines, thus allows fluorescence imaging in cells and in xenograft tumor model in mice. In this study, we find that the chlorin conjugate is the more promising theranostic agent.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chlorins; Fluorescence imaging; Glycosylation; Photodynamic therapy; Phthalocyanines; Theranostics

Mesh:

Substances:

Year:  2019        PMID: 31918951     DOI: 10.1016/j.bmc.2019.115259

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Design of novel substituted phthalocyanines; synthesis and fluorescence, DFT, photovoltaic properties.

Authors:  Mehmet Salih AĞirtaŞ; Derya GÜngÖrdÜ SolĞun; Ümit Yildiko; Abdullah Özkartal
Journal:  Turk J Chem       Date:  2020-12-16       Impact factor: 1.239

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.